Food Allergy News and Research

NJ Residents: Contact Your Local Representatives About Elemental Formula Bill

If you live in New Jersey, take action now by urging your local representative in the New Jersey state legislature to move a bill through the legislative process that covers the cost of special formula for eosinophilic disorders regardless of delivery method. The bill, S2649, gives health insurance coverage for amino acid-based elemental formulas (like Neocate® or EleCare®) for eosinophilic disorders. The bill provides coverage for elemental formula no matter how it is delivered. An infant...

AUVI-Q® Epinephrine Auto-Injectors Now Available Through Direct Delivery

People at risk for anaphylaxis can begin ordering AUVI-Q® epinephrine auto-injectors today through Kaléo’s direct delivery service. According to the company, it is also launching its AUVI-Q Afford Ability ™ program: People with commercial insurance will have an out-of-pocket cost of $0 - even if their insurance company will not cover AUVI-Q. That also applies to those with high-deductible plans. For patients who do not have government or commercial insurance, and have a household income of...

Help Drive the Future of Food Allergy Research

Does your family have food allergies? If so, we invite you to inform food allergy research. Our Food Allergy Patient & Family Registry (Registry) is a web-based program that gives you a place to share your experiences. The Registry is a program to collect, manage and analyze data from and about people with food allergies. It will advance research through patient information. Our goal is to find ways to prevent and cure food allergy. The first and only “patient-centered” food allergy...

What Are Your Options for Epinephrine Auto-Injectors?

Epinephrine is a lifesaving medicine for people with severe allergies. It’s awful to think that some Americans have to choose between putting food on the table and putting an epinephrine auto-injector in their child’s backpack. It is important to discuss with your physician about what is the most appropriate prescription for your family. You may also need to find out which options your insurance provider prefers. This will affect your out-of-pocket costs. Each device has its own unique set...

WEBINAR: Reducing Risk of Peanut Allergy – A Review of New Guidelines

New guidelines released in 2017 may help prevent the development of peanut allergy. The guidelines recommend early introduction of peanut-containing foods to infants as early as 4 and 6 months of age. How peanut-containing foods should be introduced to infants depends on the infant’s risk level. Join us for a free webinar on January 26, 2017 at 3 pm EST.

CVS Health Announces Low Priced Generic Epinephrine Auto-Injector

[PRESS RELEASE] CVS Health Offers Patients Lowest Cash Price in the Market for Generic Epinephrine Auto-injector to Treat Allergic Reactions Generic epinephrine auto-injector from Impax Laboratories available at CVS Pharmacy at cash price 80% lower than EpiPen® WOONSOCKET, R.I, Jan. 12, 2017 /PRNewswire/ -- CVS Health (NYSE: CVS ) today announced that a low-cost epinephrine auto-injector option, the authorized generic for Adrenaclick® manufactured by Impax Laboratories (IPXL), is available...

New Guidelines for Early Introduction of Peanut

For years, guidelines told us that parents and pediatricians should delay giving peanut-containing foods to children until after age three. However, all of our best evidence now shows that early introduction of peanut-containing foods is associated with less peanut allergy.

New Generic Option for EpiPen Epinephrine Auto-Injectors

Kids With Food Allergies is sharing news from Mylan about the availability of generic epinephrine auto-injectors. Mylan announced earlier this year that it would be releasing a generic alternative to its own branded EpiPen® Auto-Injector to address cost concerns. Mylan announced Friday it is launching its first authorized generic (AG) for EpiPen Auto-Injector. The company is releasing details at a new website: MyGenericEAI.com . The website includes a coupon for a $25 savings card for the...

AAFA Co-Sponsored Report Provides Recommendations for Food Allergy Research, Treatment, and Policy

[Press Release] PR Contact: Adam Bailine, Vice President, Marketing & Communications (202) 466-7643, ext. 254 abailine@aafa.org AAFA Co-Sponsored Report Provides Recommendations for Food Allergy Research, Treatment, and Policy With support from the Asthma and Allergy Foundation of America (AAFA), the National Academies of Sciences, Engineering, and Medicine releases a monumental report that makes recommendations to increase our understanding of and approaches to food allergies November...

Join Us for the Release of a Monumental Food Allergy Report

If you have a child with food allergies, finding resources to help keep your family safe is a top priority. That's why we at AAFA are proud to have co-sponsored a report with the National Academies of Sciences, Engineering, and Medicine that recommends ways to increase our understanding of and approaches to food allergies so that we can keep children safe. This exciting report, “Finding a Path to Safety in Food Allergy: Assessment of the Global Burden, Causes, Prevention, Management, and...

×
×
×
×